High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14522891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• "Presence of Fetal DNA in Maternal Plasma and Serum" (1997), by Dennis Lo, et al

  2018cited by this paper
• Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis.

  2003cited by this paper
• Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer.

  2002cited by this paper
• Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments.

  2002cited by this paper
• Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays.

  2002cited by this paper
• Microsatellite analysis—DNA test in urine competes with cystoscopy in follow‐up of superficial bladder carcinoma

  2001cited by this paper
• Detection of Mutant K-RAS Sequences in the Urine of Cancer Patients

  2001cited by this paper
• Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer

  2000cited by this paper
• Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.

  2000cited by this paper
• Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism.

  2000cited by this paper
• Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays

  2000cited by this paper
• Rapid clearance of fetal DNA from maternal plasma.

  1999cited by this paper
• Estimates of the worldwide incidence of 25 major cancers in 1990

  1999cited by this paper
• Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients.

  1999cited by this paper
• Comparison of screening methods in the detection of bladder cancer.

  1999cited by this paper
• Assessment of microsatellite instability in urine in the detection of transitional‐cell carcinoma of the bladder

  1998cited by this paper
• A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors.

  1998cited by this paper
• Induction of microsatellite instability by oxidative DNA damage.

  1998cited by this paper
• Detection of bladder cancer recurrence by microsatellite analysis of urine

  1997cited by this paper
• A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer.

  1997cited by this paper
• Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.

  1997cited by this paper
• Presence of fetal DNA in maternal plasma and serum.

  1997cited by this paper
• Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.

  1997cited by this paper
• Nucleic acid-based methods for the detection of cancer.

  1997cited by this paper
• Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance.

  1996cited by this paper
• Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis

  1996cited by this paper
• Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis.

  1996cited by this paper
• Partial allelotype of carcinoma in situ of the human bladder.

  1995cited by this paper
• Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.

  1995cited by this paper
• Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

  1995cited by this paper
• Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis.

  1995cited by this paper
• [Urine cytology].

  1995cited by this paper
• Cancer statistics, 1994

  1994cited by this paper
• Epidemiology and etiology of bladder cancer.

  1992cited by this paper
• Epidemiology and etiology of bladder cancer.

  1992cited by this paper
• Identification of p53 gene mutations in bladder cancers and urine samples.

  1991cited by this paper
• Tobacco and bladder cancer in males: Increased risk for inhalers and smokers of black tobacco

  1989cited by this paper
• Natural history and treatment of low and high risk superficial bladder tumors.

  1988cited by this paper
• Carcinoma in situ of the urinary bladder. Clinical presentation, cytologic pattern and stromal changes.

  1986cited by this paper

• Development of Multiplex Polymerase Chain Reaction (PCR)-Based MSA Assay for Bladder Cancer Detection

  2023cites this paper
• Results Obtained from a Pivotal Validation Trial of a Microsatellite Analysis (MSA) Assay for Bladder Cancer Detection through a Statistical Approach Using a Four-Stage Pipeline of Modern Machine Learning Techniques

  2023cites this paper
• Qualification of the Microsatellite Instability Analysis (MSA) for Bladder Cancer Detection: The Technical Challenges of Concordance Analysis

  2023cites this paper
• Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions

  2021cites this paper
• Urinmarker beim Blasenkarzinom

  2018cites this paper
• Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing

  2017cites this paper
• High-performance detection of somatic D-loop mutation in urothelial cell carcinoma patients by polymorphism ratio sequencing

  2016cites this paper
• Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing

  2016cites this paper
• Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence

  2016cites this paper
• Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?

  2014cites this paper
• Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer.

  2013cites this paper
• Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma

  2013influential citation
• Urine‐based Biomarkers

  2012cites this paper
• Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test.

  2011cites this paper
• Bladder cancer: translating molecular genetic insights into clinical practice.

  2011cites this paper
• Detection and quantification of rare mutations with massively parallel sequencing

  2011cites this paper
• Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

  2010cites this paper
• Detection of Genomic Duplications and Deletions

  2010cites this paper
• Evaluation of urinary proepithelin as a potential biomarker for bladder cancer detection and prognosis in Egyptian patients

  2010cites this paper
• TIMP3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer

  2009cites this paper
• High-throughput biology in the postgenomic era.

  2009cites this paper
• Association between Lifestyle Factors and CpG Island Methylation in a Cancer-Free Population

  2009cites this paper
• Contemporary diagnosis of bladder cancer.

  2008cites this paper
• High throughput molecular diagnostics in bladder cancer — on the brink of clinical utility

  2008cites this paper
• Use of Single-Nucleotide Polymorphism Array for Tumor Aberrations in Gene Copy Numbers

  2008cites this paper
• ESTUDIO MOLECULAR Y CITOGENÉTICO DEL CARCINOMA UROTELIAL: DETECCIÓN TEMPRANA DE LA ENFERMEDAD Y DE SU DISEMINACIÓN

  2008cites this paper
• Detection of Mutated K‐ras DNA in Urine, Plasma, and Serum of Patients with Colorectal Carcinoma or Adenomatous Polyps

  2008cites this paper
• Allelic Imbalance Analysis Using a Single-Nucleotide Polymorphism Microarray for the Detection of Bladder Cancer Recurrence

  2008cites this paper
• Gene signatures for risk-adapted treatment of bladder cancer

  2008cites this paper
• Tissue inhibitor of metalloproteinases-3 promoter methylation is an independent prognostic factor for bladder cancer.

  2008cites this paper
• Urinmarker und zellbasierte Nachweisverfahren beim Urothelkarzinom

  2007cites this paper
• Allelic loss analysis by denaturing high‐performance liquid chromatography and electrospray ionization mass spectrometry

  2007cites this paper
• Recent advances in high-throughput molecular marker identification for superficial and invasive bladder cancers.

  2007influential citation
• The application of single nucleotide polymorphism microarrays in cancer research.

  2007cites this paper
• Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target

  2007cites this paper
• Detection of Newly Diagnosed Bladder Cancer, Bladder Cancer Recurrence and Bladder Cancer in Patients with Hematuria Using Quantitative RT-PCR of Urinary Survivin

  2007cites this paper
• High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers.

  2006cites this paper
• Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer

  2006cites this paper
• Molecular Biomarkers for Cancer Detection in Blood and Bodily Fluids

  2006cites this paper
• Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.

  2006cites this paper
• High-throughput biology in the postgenomic era.

  2006cites this paper
• Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays

  2006cites this paper
• Yüzeyel Mesane Tümörlerinde Tanısal ve Prognostik Yeni Belirleyiciler

  2006cites this paper
• Biosensores y Biochips, herramientas para el diagnóstico y la terapéutica

  2006cites this paper
• High throughput comparative genomic hybridization array analysis of multifocal urothelial cancers

  2006cites this paper
• Novel Diagnostic Markers and Prognosticators in Superficıal Bladder Cancer

  2006cites this paper
• Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation.

  2006cites this paper
• Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?

  2006cites this paper
• Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.

  2006cites this paper
• Highlights from the Society of Urologic Oncology 4th annual meeting.

  2005cites this paper
• Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.

  2005cites this paper
• High-Resolution Mapping of Structural Mutations in Prostate Cancer With Single Nucleotide Polymorphism Arrays

  2005cites this paper
• Bladder cancer clinical trials.

  2005cites this paper
• Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

  2005cites this paper
• Mitochondria As A Target For Early Detection and Diagnosis of Cancer

  2005cites this paper
• Challenges for Biomarkers in Cancer Detection

  2004cites this paper
• New molecular markers for bladder cancer detection

  2004cites this paper
• High sensitivity EndoV mutation scanning through real-time ligase proofreading.

  2004cites this paper
• Recent advances in bladder cancer diagnostics.

  2004cites this paper
• Inferring Loss-of-Heterozygosity From Tumor-only Samples Using High-Density Oligonucleotide SNP Arrays

  year unknowncites this paper